BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21618026)

  • 1. Transcatheter closure of perimembranous ventricular septal defects (VSD) with VSD occluder: early and mid-term results.
    Wei Y; Wang X; Zhang S; Hou L; Wang Y; Xu Y; Sun Q; Zhao H
    Heart Vessels; 2012 Jul; 27(4):398-404. PubMed ID: 21618026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical analysis of transcatheter closure of perimembranous ventricular septal defects with occluders made in China.
    Li X; Li L; Wang X; Zhao HB; Zhang SY
    Chin Med J (Engl); 2011 Jul; 124(14):2117-22. PubMed ID: 21933612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder.
    Lee SM; Song JY; Choi JY; Lee SY; Paik JS; Chang SI; Shim WS; Kim SH
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1141-6. PubMed ID: 23554093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results.
    Butera G; Carminati M; Chessa M; Piazza L; Micheletti A; Negura DG; Abella R; Giamberti A; Frigiola A
    J Am Coll Cardiol; 2007 Sep; 50(12):1189-95. PubMed ID: 17868812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder.
    Zhou D; Pan W; Guan L; Ge J
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):666-74. PubMed ID: 22109986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of a perimembranous ventricular septal defect with Nit-Occlud Lê VSD Coil: A French multicentre study.
    Houeijeh A; Godart F; Jalal Z; Ovaert C; Heitz F; Mauran P; Baruteau AE; Guirguis L; Hadeed K; Baudelet JB; Iriart X; Aldebert P; Acar P; Fraisse A; Odemis E; Karsenty C; Thambo JB; Hascoët S
    Arch Cardiovasc Dis; 2020 Feb; 113(2):104-112. PubMed ID: 31982353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II.
    Ghosh S; Sridhar A; Sivaprakasam M
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):921-924. PubMed ID: 28707408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.
    El Said HG; Bratincsak A; Gordon BM; Moore JW
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):895-903. PubMed ID: 22907908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcomes of post-procedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect.
    Yang R; Kong XQ; Sheng YH; Zhou L; Xu D; Yong YH; Sun W; Zhang H; Cao KJ
    JACC Cardiovasc Interv; 2012 Apr; 5(4):422-7. PubMed ID: 22516400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results.
    Li P; Zhao XX; Zheng X; Qin YW
    Heart Vessels; 2012 Jul; 27(4):405-10. PubMed ID: 21643813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: Midterm outcomes of the first middle-eastern experience.
    Haddad RN; Daou LS; Saliba ZS
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E295-E302. PubMed ID: 31886940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous closure of perimembranous ventricular septal defects utilizing almost ideal Amplatzer Duct Occluder II: Why limitation in sizes?
    Esmaeili A; Behnke-Hall K; Schrewe R; Schranz D
    Congenit Heart Dis; 2019 May; 14(3):389-395. PubMed ID: 30561883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a modified approach to transcatheter closure of perimembranous ventricular septal defects.
    Landman G; Kipps A; Moore P; Teitel D; Meadows J
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):143-9. PubMed ID: 23225758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Closure of Perimembranous and Intracristal Ventricular Septal Defects Using Amplatzer Duct Occluder II in Children.
    Liu S; Zhang W; Li J; Wang S; Qian M; Shi J; Xie Y; Zhang Z
    J Interv Cardiol; 2021; 2021():4091888. PubMed ID: 34621141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience.
    Udink Ten Cate FEA; Sobhy R; Kalantre A; Sachdev S; Subramanian A; Koneti NR; Kumar RK; Hamza H; Jayranganath M; Sreeram N
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):82-88. PubMed ID: 30208249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.
    Velasco-Sanchez D; Tzikas A; Ibrahim R; Miró J
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):474-9. PubMed ID: 22431366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: A single-center experience on 1046 cases.
    Bai Y; Xu XD; Li CY; Zhu JQ; Wu H; Chen SP; Chen F; You XH; Zhao XX; Qin YW
    Heart Rhythm; 2015 Oct; 12(10):2132-40. PubMed ID: 25981147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil.
    Chungsomprasong P; Durongpisitkul K; Vijarnsorn C; Soongswang J; Lê TP
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1032-40. PubMed ID: 21648053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postimplant complications with transcatheter closure of congenital perimembranous ventricular septal defects: a single-center, longitudinal study from 2002 to 2011.
    Jin Y; Han B; Zhang J; Zhuang J; Yan J; Wang Y
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):666-73. PubMed ID: 22936471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial.
    Fu YC; Bass J; Amin Z; Radtke W; Cheatham JP; Hellenbrand WE; Balzer D; Cao QL; Hijazi ZM
    J Am Coll Cardiol; 2006 Jan; 47(2):319-25. PubMed ID: 16412854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.